Parallel Advisors, LLC Sage Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,511 shares of SAGE stock, worth $7,328. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,511

Previous 152 894.08%

Holding current value

$7,328

Previous $1,000 900.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.02 - $13.08 $9,540 - $17,775	1,359 Added 894.08%	1,511 $10,000
Q2 2024 Aug 08, 2024	SELL	$10.58 - $17.9 $8,844 - $14,964	-836 Reduced 84.62%	152 $1,000
Q4 2023 Feb 09, 2024	BUY	$17.1 - $22.26 $7,404 - $9,638	433 Added 78.02%	988 $21,000
Q3 2023 May 20, 2024	BUY	$16.75 - $48.98 $7,520 - $21,992	449 Added 423.58%	555 $11,000
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $7,520 - $21,992	449 Added 423.58%	555 $11,000
Q2 2023 May 20, 2024	BUY	$40.65 - $59.54 $243 - $357	6 Added 6.0%	106 $4,000
Q2 2023 Aug 04, 2023	BUY	$40.65 - $59.54 $243 - $357	6 Added 6.0%	106 $4,000
Q1 2023 May 20, 2024	SELL	$37.27 - $46.57 $33,095 - $41,354	-888 Reduced 89.88%	100 $4,000
Q4 2022 Feb 03, 2023	SELL	$32.2 - $43.61 $225 - $305	-7 Reduced 6.54%	100 $3,000
Q3 2022 Nov 10, 2022	SELL	$32.28 - $43.27 $1,323 - $1,774	-41 Reduced 27.7%	107 $4,000
Q2 2022 Aug 01, 2022	BUY	$27.52 - $37.99 $4,072 - $5,622	148 New	148 $5,000
Q1 2022 Apr 28, 2022	SELL	$30.71 - $45.71 $5,404 - $8,044	-176 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$37.06 - $47.11 $1,408 - $1,790	-38 Reduced 17.76%	176 $7,000
Q3 2021 Nov 02, 2021	BUY	$40.26 - $57.37 $4,187 - $5,966	104 Added 94.55%	214 $9,000
Q3 2020 Oct 27, 2020	BUY	$41.13 - $62.45 $3,701 - $5,620	90 Added 450.0%	110 $7,000
Q2 2020 Jul 16, 2020	SELL	$25.95 - $43.15 $3,918 - $6,515	-151 Reduced 88.3%	20 $0
Q1 2020 Apr 27, 2020	BUY	$26.15 - $77.24 $4,471 - $13,208	171 New	171 $4,000
Q4 2019 Jan 30, 2020	SELL	$60.18 - $154.77 $1,624 - $4,178	-27 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$89.33 - $163.65 $2,411 - $4,418	27 New	27 $4,000
Q4 2018 Feb 05, 2019	SELL	$81.94 - $139.71 $737 - $1,257	-9 Closed	0 $0
Q3 2018 Nov 01, 2018	SELL	$138.11 - $169.04 $1,104 - $1,352	-8 Reduced 47.06%	9 $1,000
Q2 2018 Jul 30, 2018	SELL	$140.36 - $175.76 $561 - $703	-4 Reduced 19.05%	17 $2,000
Q1 2018 May 08, 2018	BUY	$152.15 - $192.33 $3,195 - $4,038	21 New	21 $3,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $288M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Sage Therapeutics, Inc. Transaction History